CancerVax Activates Human Killer T-Cells Against Cancer
LEHI, Utah, August 6, 2026 CancerVax announced a significant preclinical milestone with new in vitro findings demonstrating that its...
lipid nanoparticles
Advertisement
Galmed Accelerates Heart Failure Innovation with Aramchol
RAMAT-GAN, Israel, July 16, 2026 Galmed Pharmaceuticals Ltd. has announced the breakthrough development of a novel lipid nanoparticle (LNP)...
Jackson Laboratory Wins ARPA-H Funding for Rare CNS Diseases
BAR HARBOR, Maine, USA, July 9, 2026 The Jackson Laboratory (JAX), in collaboration with the Broad Institute and a...
GEMMABio Receives ARPA-H Grant for Precision Gene Editing
PHILADELPHIA, Pennsylvania, USA, July 9, 2026 GEMMA Biotherapeutics (GEMMABio) has been awarded funding from the Advanced Research Projects Agency...
Resolution Therapeutics Expands Regenerative Macrophage Therapy with In Vivo Platform
EDINBURGH & LONDON, UK, June 17, 2026 Resolution Therapeutics announced the expansion of its pipeline for inflammatory and fibrotic...
Advertisements
Waters Launches New Platform for GLP-1 and LNP Analytics
MILFORD, Massachusetts, USA – June 8, 2026 Waters Corporation has introduced its BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and...
Lilly Acquires Engage Bio for Genetic Medicines
SAN CARLOS, Calif., May 22, 2026 Eli Lilly and Company has acquired Engage Bio, a preclinical biotechnology company focused...
ReCode Achieves First Clinical Success for Inhaled mRNA Therapy in PCD
MENLO PARK, California, May 20, 2026 ReCode Therapeutics announced positive clinical data from its RCT1100 inhaled mRNA therapy program...
Mirai Bio Expands LNP Delivery Into Adipocyte Tissue
CAMBRIDGE, Mass., May 14, 2026 Mirai Bio presented new preclinical data at the American Society of Gene and Cell...
Mirai Bio Advances In Vivo CAR-T Platform at ASGCT
CAMBRIDGE, Mass., May 12, 2026 Mirai Bio unveiled new preclinical data at the American Society of Gene and Cell...
Advertisement
